BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33689776)

  • 21. Pediatric morphea.
    Browning JC
    Dermatol Clin; 2013 Apr; 31(2):229-37. PubMed ID: 23557652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.
    Peterson LS; Nelson AM; Su WP; Mason T; O'Fallon WM; Gabriel SE
    J Rheumatol; 1997 Jan; 24(1):73-80. PubMed ID: 9002014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases.
    Marzano AV; Menni S; Parodi A; Borghi A; Fuligni A; Fabbri P; Caputo R
    Eur J Dermatol; 2003; 13(2):171-6. PubMed ID: 12695134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized scleroderma: a clinical study at a single center in Korea.
    Noh JW; Kim J; Kim JW
    Int J Rheum Dis; 2013 Aug; 16(4):437-41. PubMed ID: 23992265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of multiple cerebral cavernomas associated with en coup de sabre scleroderma.
    Alwash N; Dinani N; Felton J
    Pediatr Dermatol; 2020 Jan; 37(1):237-238. PubMed ID: 31755138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Linear scleroderma "en coup de sabre" causing severe neurological and ocular symptoms].
    Stroh H; Jaschinski C; Enk A; Toberer F
    Hautarzt; 2020 Oct; 71(10):802-804. PubMed ID: 32533203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients.
    Tollefson MM; Witman PM
    J Am Acad Dermatol; 2007 Feb; 56(2):257-63. PubMed ID: 17147965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations?
    Valões CCM; Novak GV; Brunelli JB; Kozu KT; Toma RK; Silva CA
    Rev Bras Reumatol Engl Ed; 2017; 57(6):521-525. PubMed ID: 29173689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized scleroderma: clinical and epidemiological features with emphasis on adulthood- versus childhood-onset disease differences.
    Lis-Święty A; Skrzypek-Salamon A; Ranosz-Janicka I; Brzezińska-Wcisło L
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1595-1603. PubMed ID: 28271552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
    Kim A; Marinkovich N; Vasquez R; Jacobe HT
    J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center.
    Kreuter A; Wischnewski J; Terras S; Altmeyer P; Stücker M; Gambichler T
    J Am Acad Dermatol; 2012 Dec; 67(6):1157-62. PubMed ID: 22533994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicohistopathological correlations in juvenile localized scleroderma: studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes.
    Sung JJ; Chen TS; Gilliam AC; McCalmont TH; Gilliam AE
    J Am Acad Dermatol; 2011 Aug; 65(2):364-373. PubMed ID: 21570153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of juvenile idiopathic arthritis and morphea: a case series.
    Giani T; Madera A; Cimaz R
    Clin Rheumatol; 2020 Apr; 39(4):1341-1345. PubMed ID: 31838640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphea in Childhood: An Update.
    Aranegui B; Jiménez-Reyes J
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):312-322. PubMed ID: 29248149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and management of morphea and lichen sclerosus and atrophicus in children.
    Pope E; Laxer RM
    Pediatr Clin North Am; 2014 Apr; 61(2):309-19. PubMed ID: 24636648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
    Johnson W; Jacobe H
    J Am Acad Dermatol; 2012 Nov; 67(5):881-9. PubMed ID: 22382198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for morphoea disease severity: a retrospective review of 114 paediatric patients.
    Pequet MS; Holland KE; Zhao S; Drolet BA; Galbraith SS; Siegel DH; Chiu YE
    Br J Dermatol; 2014 Apr; 170(4):895-900. PubMed ID: 24341905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea.
    García-Romero MT; Tollefson M; Pope E; Brandling-Bennett HA; Paller AS; Keimig E; Arkin L; Wanat KA; Humphrey SR; Werth VP; Oza V; Jacobe H; Fett N; Cordoro KM; Medina-Vera I; Chiu YE
    JAMA Dermatol; 2023 Mar; 159(3):299-307. PubMed ID: 36753150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localized scleroderma.
    Tuffanelli DL
    Semin Cutan Med Surg; 1998 Mar; 17(1):27-33. PubMed ID: 9512104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of long-term outcomes in adults with pediatric-onset morphea.
    Saxton-Daniels S; Jacobe HT
    Arch Dermatol; 2010 Sep; 146(9):1044-5. PubMed ID: 20855712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.